Exencial Wealth Advisors LLC Has $3.92 Million Position in OneMedNet Corporation $ONMD

Exencial Wealth Advisors LLC grew its position in OneMedNet Corporation (NASDAQ:ONMDFree Report) by 141.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,599,460 shares of the company’s stock after acquiring an additional 2,107,598 shares during the period. Exencial Wealth Advisors LLC owned about 7.32% of OneMedNet worth $3,923,000 at the end of the most recent quarter.

Insiders Place Their Bets

In related news, CEO Aaron Green sold 61,555 shares of the business’s stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $1.20, for a total value of $73,866.00. Following the completion of the sale, the chief executive officer directly owned 1,804,103 shares in the company, valued at $2,164,923.60. The trade was a 3.30% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 46.20% of the company’s stock.

OneMedNet Stock Performance

Shares of ONMD stock opened at $1.10 on Thursday. OneMedNet Corporation has a 52 week low of $0.30 and a 52 week high of $4.22. The company has a market capitalization of $56.11 million, a price-to-earnings ratio of -22.00 and a beta of 1.15. The company has a 50-day simple moving average of $1.38 and a 200 day simple moving average of $1.22.

OneMedNet (NASDAQ:ONMDGet Free Report) last released its quarterly earnings results on Friday, November 14th. The company reported ($0.01) earnings per share for the quarter. The business had revenue of $0.18 million for the quarter.

Analyst Ratings Changes

Several brokerages recently issued reports on ONMD. Weiss Ratings reiterated a “sell (d-)” rating on shares of OneMedNet in a research note on Friday, January 9th. Wall Street Zen upgraded OneMedNet to a “hold” rating in a research note on Friday, September 26th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, OneMedNet currently has an average rating of “Sell”.

Read Our Latest Research Report on ONMD

OneMedNet Profile

(Free Report)

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.

Featured Articles

Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.